Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
Jinkai Zang(The Ohio State University), Zhong Huang(Shenzhen University), Qiang Deng(Kunming University of Science and Technology), Yufang Yi(Hainan Medical University), Yannan Yin(Fudan University), Feifei Yin(Chinese Academy of Sciences), Shiqi Xu(Institut Pasteur of Shanghai), Gaowei Hu(Shanghai Medical College of Fudan University), Yuanfei Zhu(Shanghai Medical College of Fudan University), Shujuan Du(Shanghai Medical College of Fudan University), Yong Yang(Chinese Academy of Sciences), Shuxia Wang(Beijing Institute of Petrochemical Technology), Chao Zhang(Fudan University), Youhua Xie(Shanghai Medical College of Fudan University), Chenjian Gu(Washington University in St. Louis), Yalei Wang(Institut Pasteur of Shanghai), Xueyang Zhang(Xuzhou University of Technology), Haikun Wang(Peking University), Yu Zhou(Yangtze University)
Cited by 70
Related Papers
Biochar technology in wastewater treatment: A critical review
|Chemosphere|2020|846
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
|Protein & Cell|2020|397
Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples
|Nature Biomedical Engineering|2022|332
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
|Nature Communications|2021|299